Table 2.
Concentration | BPA | BPA-DM | nNP | nOP |
---|---|---|---|---|
0.1% DMSO | 1.03 ± 0.04 | 1.00 ± 0.05 | 0.98 ± 0.07 | 0.99 ± 0.04 |
60 pM TCDD | 14.84 ± 6.26* | 14.84 ± 6.26* | 13.89 ± 7.32* | 13.89 ± 7.32* |
Compounds alone | ||||
1.0 × 10−8 M | 1.15 ± 0.21 | 1.15 ± 0.23 | 1.30 ± 0.30 | 1.34 ± 0.27* |
2.5 × 10−8 M | 1.07 ± 0.21 | 1.11 ± 0.23 | 1.17 ± 0.22 | 1.27 ± 0.21* |
5.0 × 10−8 M | 1.11 ± 0.14 | 1.10 ± 0.08 | 1.30 ± 0.12* | 1.18 ± 0.11 |
1.0 × 10−7 M | 1.07 ± 0.20 | 1.12 ± 0.25 | 1.19 ± 0.13* | 1.20 ± 0.20 |
1.0 × 10−6 M | 1.22 ± 0.36 | 1.02 ± 0.09 | 1.47 ± 0.20* | 1.08 ± 0.17 |
1.0 × 10−5 M | 1.43 ± 0.33 | 1.37 ± 0.27* | 3.91 ± 1.23* | 1.00 ± 0.29 |
2.5 × 10−5 M | 1.20 ± 0.37 | 1.15 ± 0.28 | 6.19 ± 2.22* | 0.79 ± 0.25 |
5.0 × 10−5 M | 0.73 ± 0.12* | 0.86 ± 0.16 | 7.99 ± 1.64* | 0.41 ± 0.03* |
1.0 × 10−4 M | 0.46 ± 0.15* | 0.97 ± 0.25 | 3.68 ± 0.20* | 0.54 ± 0.19* |
Compounds + TCDD | ||||
60 pM TCDD | 1.08 ± 0.19 | 1.10 ± 0.25 | 0.98 ± 0.03 | 1.04 ± 0.06 |
1.0 × 10−8 M | 1.14 ± 0.15 | 1.44 ± 0.33 | 1.17 ± 0.24 | 1.18 ± 0.12 |
2.5 × 10−8 M | 1.13 ± 0.06 | 1.48 ± 0.60 | 1.13 ± 0.16 | 1.22 ± 0.19 |
5.0 × 10−8 M | 1.34 ± 0.33 | 1.53 ± 0.45 | 1.19 ± 0.13 | 1.12 ± 0.09 |
1.0 × 10−7 M | 1.23 ± 0.11 | 1.64 ± 0.62 | 1.14 ± 0.19 | 1.18 ± 0.15 |
1.0 × 10−6 M | 1.18 ± 0.27 | 1.57 ± 0.56 | 1.22 ± 0.22 | 1.15 ± 0.14 |
1.0 × 10−5 M | 1.40 ± 0.37 | 1.86 ± 0.76 | 1.34 ± 0.35 | 1.24 ± 0.20 |
2.5 × 10−5 M | 1.36 ± 0.42 | 1.44 ± 0.35 | 1.46 ± 0.38* | 1.34 ± 0.45 |
5.0 × 10−5 M | 0.93 ± 0.16 | 1.23 ± 0.21 | 1.41 ± 0.36* | 1.10 ± 0.39 |
1.0 × 10−4 M | 0.44 ± 0.13* | 0.56 ± 0.29 | 0.61 ± 0.22* | 0.41 ± 0.11* |
Concentrations up to 10−4 M were not cytotoxic to the cells, whereas concentrations > 10−4 M elicited cytotoxicity to the Hepa1.1 2cR cell. The results given refer to effects observed at concentrations eliciting no cytotoxicity (n ≥ 3).
p < 0.05, versus the respective control, which was set to 1.